APOE and Alzheimer disease: In a secondary analysis that controlled for demographics and APOE ε4, p-tau181 (OR = 2.48, 95% CI = 1.54–4.00) and p-tau217 (OR = 3.76, 95% CI = 2.21–5.08) remained strongly associated with AD.